Formal sale of Indian unit to begin soon: Adcock

South Africa’s pharmaceutical firm Adcock Ingram told BioSpectrum that it is yet to initiate a formal sale process to dispose of its Indian business unit Cosme Farma, located in Goa


(Photo Courtesy:

In its year-end 2015 financial report, Adcock expressed concerns over the underperformance of Cosme.

"As time has evolved, management has recognized the difficulties of operating an enterprise in such a competitive pharmaceutical market (India), which, in relative terms is sub scale, requiring inter alia, and significant further investment.

"In 2014 financial year, given the losses incurred, after the obligatory internal intangible asset amortization, the Cosme Pharma investment was impaired by an amount of R278 million," Adcock revealed.

The trading loss of R56.8 million, incurred in the current financial year, dictated that a further impairment of R74.4 million would be appropriate, it said.

The Group's Cosme Pharma was acquired in early 2013 for Rs 480 crore.


Previous 1 3 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box


GST: Boon or Bane for Healthcare?

Send this article by email